Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
characterization is highly appreciated. We are looking for committed and creative individuals able to work in a team. The candidate will work in a top-level research environment with state-of-the-art laboratory
-
enhancing our understanding and management of critical resources such as water and energy, as well as geohazards. Switzerland is already heavily affected by climate change, with long hot and dry periods in
-
how perishable biological products react inside cold chain unit operations and to pinpoint why some products decay faster. For that purpose, we develop digital twins of the cargo, based on measured air
-
papers, presenting findings at conferences and managing your dissertation. During the first two years of your PhD, you will also assist the Chair in teaching. In addition, you will support knowledge
-
to compliance with export-control and embargo legislation . The committee will also consider the applicant’s specific research topic as well as the thesis supervisor(s) the applicant would like to work with
-
of such tumors Establishment of a unique 3D micro-CT histology data base for recurrent thyroid carcinomas Data management, data treatment Extension and coupling with high-field MRI technology towards in-vivo
-
The University of Basel, Switzerland, invites applications for a PhD researcher position (100% FTE) for the project Aspirational Urbanism and the Recodification of Defiance (ASPIRA). The function
-
. Empa is a research institution of the ETH Domain. The Laboratory of High Performance Ceramics is offering a PhD position focused on the development of new catalytic materials for CO2 conversion
-
. Empa is a research institution of the ETH Domain. Your tasks Your tasks will focus on the design and operation of experiments to investigate the failure mechanisms in wooden structures. This will require
-
of this project, you will work with a team of scientists with backgrounds in chemistry, cell biology and microbiology as well as with clinical partners on the development of engineered corneal transplant to treat